Severe bleeding diathesis associated with moxalactam administration.
A case is presented of a severe bleeding diathesis associated with moxalactam administration that was confirmed on rechallenge. Potential mechanisms of action and recommendations for patient monitoring are discussed.
D006474:Hemorrhagic Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009070:Moxalactam / Q000009:adverse effects*; D014812:Vitamin K / Q000502:physiology
D014812:Vitamin K; D009070:Moxalactam